IBC’s Genome Editing Applications conference will showcase the most up-to-date therapeutic and biomedical applications emerging using CRISPRs, ZFNs, TALENs, AAVs and other genome engineering technologies. From validation of targeted cell lines and development of transgenic animal models to therapeutic uses in cell therapy, gene therapy and immunotherapy, this event will also highlight applications in drug target identification/validation and lead discovery and explore how these technologies are being used for whole-genome and functional screening as well as basic research applications.
- Conferences
- Genome Editing Applications 2015
Genome Editing Applications 2015
IBC Life Sciences - 18 Mar 2015
Summary
Topics
Details
Meeting Summary
Topics Include
- Keynotes
Two world-renowned experts in genome editing - FDA & NIH Perspective
Perspectives on genome editing from the division of cellular and gene therapies - Hot-Topic Panels
- The IP landscape of CRISPR and genome editing technologies
- Comparing the advantages and challenges of different genome editing technologies
- 18 Case Studies of therapeutic and drug discovery applications
- Industry Application Presentations from Bluebird Bio, Editas, GlaxoSmithKline, Cellectis, Sangamo, Shire, Caribou, Horizon Discovery, Pfizer, Medimmune, AstraZeneca, Janssen and Merck
Meeting Details
Date | 18 Mar 2015 |
Location | Hilton Boston back Bay Boston, MA, USA Get Directions |
Organizers | IBC |